# The skin barrier

> Alliance Aesthetics: the skin barrier — The skin barrier at Alliance Aesthetics: copper retention in skin specimens and the delivery problem behind topical GHK research.

**Copper peptide essays**

An ingredient can perform well in a dish and still present a delivery problem. Here the skin specimen takes center stage.

## A specimen between compartments

Imagine the practical question before the apparatus: what passes through skin, and what remains in it? In the [human skin-layer study, copper was applied as the GHK-Cu tripeptide and measured for permeation and retention](https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/). The setting was skin examined outside the body. That is the meaning of ex vivo here; the experiment concerns a specimen rather than the response of a person using a preparation.

Over [48 hours, the study recorded copper passage and a retained dermal depot](https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/). I like the physicality of this question. It demands an answer about location, instead of allowing the word “delivery” to stand in for a result.

The named measurement matters just as much as the apparatus. This entry describes copper permeation. Extending it to the amount of intact peptide reaching a target, or to a wrinkle change, would spend experimental credit too freely for my taste. Those questions require their own measurements.

![A pale membrane clamped between the chambers of a glass diffusion apparatus](images/diffusion-apparatus.webp)

*Staged apparatus illustration of a barrier experiment, rather than a reconstruction of the equipment used in the paper.*

## The formulation problem

The [anti-wrinkle review identifies poor stratum-corneum permeability as a central obstacle for GHK](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/). It also discusses palmitoylation and microneedle pretreatment as approaches to enhancing delivery. The stratum corneum is the skin barrier under discussion in that review; changing the route through it changes the experiment.

This gives formulation a more substantial role than the supporting part I initially assigned it. A preparation has to be considered with the ingredient, because the review is explicitly concerned with getting GHK across that barrier. I regard a delivery strategy as a research question with its own evidence burden, rather than an automatic upgrade.

## Credit for getting there

The [skin-layer study reports dermal retention](https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/) and the [anti-wrinkle review surveys enhancement strategies](https://pmc.ncbi.nlm.nih.gov/articles/PMC11830136/). They help explain why an ingredient name alone leaves so much unresolved about a topical preparation. Neither record provides a reason to treat every formulation carrying the same name as interchangeable.

I give the complete preparation a place at the table, including a comparison that could show whether changing delivery improved the intended outcome. That is where an alliance between an active ingredient and its carrier could earn its reputation. The [skin-results essay](/skin-results) turns to the outcomes themselves.

---

At Alliance Aesthetics I put copper-peptide partnerships through their paces against published research; this editorial site is not a business and supplies no medical advice.